Eur Rev Med Pharmacol Sci 2002; 6 (2): 27-32

Pathophysiology of obesity-induced insulin resistance and type 2 diabetes mellitus

P.A. Tataranni

Obesity, Diabetes & Energy Metabolism Unit, Clinical Diabetes & Nutrition Section, NIDDK-NH-DHHS, Phoenix, Az, USA

To cite this article

P.A. Tataranni
Pathophysiology of obesity-induced insulin resistance and type 2 diabetes mellitus

Eur Rev Med Pharmacol Sci
Year: 2002
Vol. 6 - N. 2
Pages: 27-32

Keywords Related articles:

  1. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on insulin resistance and adipocytokines in patients with diabetes mellitus type 2
  2. A randomized clinical trial with two enteral diabetes-specific supplements in patients with diabetes mellitus type 2: metabolic effects
  3. Effect of hypoglycemic drugs on aspirin resistance in patients with diabetes mellitus
  4. Feedback inhibition of insulin secretion and insulin resistance in polycystic ovarian syndrome with and without obesity
  5. Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study